The current one being set up at Einstein is a pre-clinical
The current one being set up at Einstein is a pre-clinical glioblastoma mouse study. It's to prove the potential of leronlimab in glioblastoma to the FDA in order to move on to an actual clinical trial. I would think this would take around 6 months. Then the FDA would have to review the data and the protocol before a human trial could commence.
The best way to obtain leronlimab would be through Federal Right to Try. Under Federal Right to Try the FDA is not involved at all. First step would be to contact Cytodyn to see if they're willing to provide leronlimab. Under the Federal Right to Try law the drug must not be on an FDA clinical hold. Since the clinical hold is only because of protocol approval for HIV immune activation that may not apply to glioblastoma. If it does apply then you'd have to wait to receive the drug after the FDA lifts the protocol hold. Best to contact Cytodyn now because if they're willing to provide leronlimab they can the minute the protocol hold is lifted.
The other avenues would be State Right to Try laws if her state has one. This can be a bit more complicated and time consuming because approval for use may need to be approved by a State medical board or be subject to other red tape. Then there's FDA compassionate use but with time being of the essence Federal Right to Try would be quicker.
16
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Blanchard Honored for Excellence in HR Blanchard, a leading global firm in leadership development and consulting, has recently received the Bronze Stevie Award for Human Resources Department of the Year at the prestigious International Business Awards. This award acknowledges the innovative initiatives undertaken by Blanchard's People and Culture team, which have greatly...
Continue Reading
Understanding e.l.f. Beauty's Current Stock Landscape e.l.f. Beauty (NYSE: ELF) has transitioned through various stock phases, culminating in a period marked by uncertainty. Having recently completed its Adhishthana Himalayan formation, the stock finds itself in a crucial structural phase. Knowing where the stock currently stands can help investors make informed decisions...
Continue Reading
AIKO Unveils Revolutionary Solar Technology AIKO has successfully made a strong statement in the Australian solar market with the introduction of its Gen 3 Infinite Series portfolio. This significant launch at All Energy Australia showcases innovative technology aimed at enhancing solar energy solutions for residential, commercial, and large-scale projects. Transformative...
Continue Reading
Unveiling Holland America's Exceptional Fare Deals Holland America Line has officially kicked off its most significant promotion of the year, the "Start Your Journey" Wave season. This offer features over 500 cruises, allowing travelers to explore stunning destinations like Alaska and Europe while enjoying up to 30% off cruise fares. With free balcony upgrades and various...
Continue Reading
Mavenir Achieves Recognition for Its Innovation Mavenir, a leading cloud-native network infrastructure provider, has recently been honored with the prestigious Advancing Artificial Intelligence Global Telecoms Award for its impactful service, Network Intelligence as a Service (NIaaS). This accolade demonstrates Mavenir's commitment to harnessing artificial intelligence...
Continue Reading